With respect to the nearly 12-fold excess for HL and the 2.2-fold excess for myeloma (borderline significance), again, our findings confirm previous reports ( Iscovich et al , 1999b ; Cannon et al , 2000 ; Serraino et al , 2007 ).
← all excerpts
Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995-2002).
1
—
—